ELIZABETH ALLEN: Open Payments
NPI 1184946170 · CLINTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$267 in 15 payments from 8 companies in 2025. Trend: 2023 $1,454 · 2024 $338 · 2025 $267
Food & beverage: $267
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $74 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Novo Nordisk Inc | 2 | $36 |
| PFIZER INC. | 2 | $35 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
Products named: UBRELVY, Symbravo, Rybelsus, ELIQUIS, VRAYLAR, NEXLETOL, JARDIANCE, VOQUEZNA.
Industry payments across MS — which companies pay providers there.
